Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
JAMA
; 328(13): 1348-1350, 2022 10 04.
Article
in En
| MEDLINE
| ID: mdl-35994281
This case series describes the clinical resolution of systemic symptoms and lesions, along with any adverse events, in patients with monkeypox infection who were treated with tecovirimat on a compassionate use basis.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Phthalimides
/
Benzamides
/
Mpox (monkeypox)
/
Compassionate Use Trials
Limits:
Humans
Language:
En
Journal:
JAMA
Year:
2022
Document type:
Article